FDA Warning Letter Recovery

What we do:

Time is of the essence!

Why we do it:

  1. Collecting and analyze current and past warning letters, all 483 observations, internal audits, GMP documentation, and related evidence.

  2. Draft a FDA Warning Letter Recovery Plan.

  3. Issue and keeping current a punch list assigning what is to be done, when it is to be done, and who is to do it.

  4. Serve as a liaison between the company and the FDA, discussing corrective actions, collecting FDA expert comments, responding to questions, and helping resolve problems.

  5. Coordinate and work with the warning letter recovery team, other staff and the FDA representatives.

  6. Research and provide applicable FDA regulations, guidance documents, notes and cases to support "appropriate" corrective actions.  This research is a key component of cost effective FDA warning letter recovery.

  7. Assist in the preparation and review of all correspondence to the FDA.

  8. Provide training for management and staff.

  9. Conduct a complete quality system audit prior to FDA's follow-up inspection.

  10. Coordinate and host FDA warning letter follow-up inspection.

  11. Provide FDA warning letter recovery progress reports to management throughout the process.

 

The Help Desk addresses warning letter recovery with urgency.  All responsibilities are handled professionally, confidentially and efficiently.

Email

or

Call us toll free: 1-888-299-0157

 

The U.S. Food and Drug Administration (FDA) regulates the labeling and sale of foods, drugs, cosmetics, biologicals, and medical devices in interstate commerce. The FDA warning letter is a serious notice that the FDA warning letter recipient appears to be violating federal law and may be subject to enforcement action if the apparent violation continues. Enforcement actions include seizure of goods, injunctions, criminal prosecutions, fines, and imprisonment.  In November 2002, Health and Human Services (HHS) deputy secretary directed the agency to stop issuing warning letters and so-called "untitled" letters that have not first been cleared for legal sufficiency and policy by the FDA chief counsel. The 2002 change in FDA warning letter policy put industry on notice that receipt of an FDA warning letter is a very serious issue and must be acted upon.

• Home • ASK Service • Buy Services • BIOs • 510K Submission • Get Quote • GMP Consulting • Client Q&A • FDA U.S.Agent • Problem Solving •


FDA Compliance Help Desk™

1289 N. Fordham Blvd. Suite A-128

Chapel Hill, NC 27517 USA

Phone 919.942.1634 

info@FDAcomplianceHelp.com

Copyright © 2004 - 2005 FDA Compliance Help Desk, Inc.
Last modified: October 16, 2005

FDA Compliance Help Desk, Inc. is a for profit NC corporation and is not affiliated with the U.S. Department of Health and Human Service.